Enjoy complimentary customisation on priority with our Enterprise License!
The Pelvic Floor Diagnostics Market size is estimated to grow by USD 161.81 million at a CAGR of 5.7% between 2023 and 2028. Market growth is driven by several factors, including the rising prevalence of urinary incontinence, the expanding geriatric population, significant growth potential in emerging economies, and heightened awareness programs for pelvic floor disorders. The increase in urinary incontinence cases, particularly among the aging population, fuels the demand for related medical solutions. Emerging economies present substantial growth opportunities due to improving healthcare infrastructure and growing consumer awareness. Additionally, initiatives aimed at raising awareness about pelvic floor disorders contribute to early diagnosis and treatment, further driving market expansion. These combined factors underscore a robust market trajectory, driven by demographic shifts, economic development, and proactive health education efforts.
To learn more about this report, Request Free Sample
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments
The ultrasound system segment is estimated to witness significant growth during the forecast period. Ultrasound Systems play a significant role in this market due to their noninvasive imaging capabilities, enabling medical teams to assess pelvic organ prolapse, urethral functions, and urinary tract issues. Ultrasound machines and consumables are essential instruments and equipment in this context. Urodynamics Systems are another crucial diagnostic technology, providing valuable information on bladder visualization, urinary tract issues, and urethral functions.
Get a glance at the market contribution of various segments Download PDF Sample
The ultrasound system segment was the largest segment and was valued at USD 106.66 million in 2018. Cystoscopes are also employed for initial evaluations and referrals to Diagnostic Centers for more comprehensive assessments and treatment plans. Specialized care for conditions like constipation, rectocele, and enterocle requires the use of diagnostic technology and medical team expertise, including Point of Care (POC) haematology diagnostics. Fecal incontinence, characterized by involuntary loss of feces, is a common pelvic floor disorder driving the demand for diagnostic tests. Other conditions, such as tumors and infections, also necessitate the use of diagnostic processes and test results for accurate patient data and effective treatment plans. Healthcare providers rely on these diagnostic tools and technologies, including POC haematology diagnostics, to ensure proper assessment and referral for specialized care when necessary. Hence, these factors are fueling the growth of this segment, which in turn drives the market growth during the forecast period.
Hospitals comprise a major end-user category and have a significant impact on the market growth of pelvic floor diagnostic devices. Patients seeking early diagnoses for pelvic floor disorders, such as prolapse, benefit significantly from the advancements in the pelvic floor diagnostics market. This market caters to various populations, including geriatric and male populations, who are more susceptible to pelvic floor disorders due to aging and lifestyle changes. Hospitals, with their large patient bases and state-of-the-art infrastructure, play a crucial role in the market's growth. These institutions offer a range of diagnostic tools, including MRI technology and telemedicine, enabling remote consultations and continuous patient monitoring. However, costly diagnostic procedures and the preference for conservative treatments, such as physical therapy, can impact market growth. Demographic shifts, driven by an aging population, further fuel the demand for pelvic floor diagnostic devices. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
There has been significant growth in the number of diagnostics imaging centers in the global pelvic floor diagnostics market over the years. Factors such as the rising demand for non-invasive diagnostic procedures and technological advancements. is fuelling the growth of this segment. In addition, due to the non-invasive nature and capacity to provide real-time imaging, imaging centers prefer to use pelvic floor diagnostics equipment. Therefore, this type of equipment is frequently used to diagnose a number of conditions, including pelvic floor disorders like urinary incontinence and fecal incontinence, among others. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Pelvic floor diagnostics is a significant sector in North America, experiencing growth due to the increasing prevalence of pelvic organ abnormalities and fecal issues. The US market holds the largest share in this region. The aging population, coupled with lifestyle changes and inadequate diet, contribute to the rise in health complications, including pelvic floor disorders such as urinary incontinence and pelvic organ prolapse.
Moreover, these conditions necessitate diagnostic tests, like Ultrasound Systems and noninvasive imaging, to assess urethral functions, urinary flow, and voiding dysfunction. Urodynamics Systems are essential for evaluating urethral functions and diagnosing urinary tract issues, such as bladder dysfunction and tumors. Fecal Incontinence, characterized by involuntary loss of stool, also requires specialized diagnostic processes. Medical teams utilize diagnostic technology, including Cystoscopes for bladder visualization and catheterization kits, to provide comprehensive assessments and develop treatment plans. Patients undergo initial evaluations and referrals to Diagnostic Centers for pelvic floor diagnostics. Faecal Incontinence, Constipation, Rectocele, and Enterocele are common conditions diagnosed through these diagnostic procedures. Instruments and Equipment, such as ultrasound machines and urodynamic systems, along with consumables, are integral components of these diagnostic processes. Patient data and test results are crucial for healthcare providers to make informed decisions and provide specialized care. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Alacer Biomedica: The company offers a pelvic floor diagnostic system called Uranus II Urodynamics equipment
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market encompasses various noninvasive imaging technologies and Urodynamics Systems used for assessing pelvic floor dysfunctions, including floor prolapse, urinary incontinence, and fecal issues. These conditions can result from injuries, medical conditions such as arthritis, or abnormalities affecting the pelvis, pubic bone, coccyx, and pelvic organs like the bladder, bowel, and uterus. Diagnostic tests play a crucial role in evaluating bladder control and identifying the risk of prolapse, as well as bowel and uterus disorders. Ultrasound Systems and Urodynamics Systems are commonly employed for pelvic floor diagnostics due to their ability to provide valuable information on the structure and function of the pelvic organs and associated muscles, ligaments, and pressure systems. The market is expected to grow significantly due to the increasing prevalence of pelvic floor dysfunctions and the need for accurate and noninvasive diagnostic tools. This growth can be attributed to the advancements in imaging technologies and the rising awareness of the importance of early diagnosis and treatment for various pelvic floor conditions. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the increase in the prevalence of urinary incontinence coupled with the rise in the geriatric population. With an aging demographic shift, the prevalence of these conditions is expected to increase. Incontinence can be attributed to various factors, including prolapse, cognitive impairment, stroke, diabetes, mobility impairment, and prostate disorders. Early diagnoses are crucial to mitigate the impact of these conditions and explore conservative treatment options, such as physical therapy. Advancements in diagnostics, including MRI technology, telemedicine, and remote consultations, enable continuous patient monitoring and more cost-effective care. Lifestyle changes can also contribute to managing symptoms.
However, for some patients, particularly those with severe cases or underlying conditions, costly diagnostic procedures may be necessary. The market caters to the needs of both male and female patients, addressing the unique challenges posed by conditions like incontinence and prolapse. As the population ages, the demand for accurate and accessible diagnostics is expected to grow, making it a vital area of focus for healthcare providers and researchers. Furthermore, the rise in the number of patients with urological disorders such as urinary incontinence, stress incontinence, bladder obstruction, prostatitis, and prostatic hyperplasia will drive the growth of the market during the forecast period.
Innovative diagnostic technologies such as chemiluminescence play a crucial role in enhancing diagnostic accuracy and efficiency within this market segment. Chemiluminescence assays are utilized for detecting biomarkers and infections, providing clinicians with valuable insights for prompt and targeted treatment strategies. This advancement underscores the evolving landscape of pelvic floor diagnostics, where advanced technologies continue to redefine patient care standards
.
A key factor shaping the market growth is the growing acquisitions by companies in the market. The companies operating in the market have been implementing various strategies to expand their product portfolio, especially over the last five years, which have significantly impacted the market. In addition, they are undergoing several business strategies such as mergers and acquisitions (M&A) and partnerships to increase their market presence and the sales of their pelvic floor diagnostics range.
Therefore, such strategies may provide an opportunity for companies to increase their profit margins. For example, in September 2023, Caldera Medical announced its acquisition of Atlantic Therapeutics, an Ireland-based medical device provider specializing in non-invasive pelvic floor strengthening and nerve-stimulating solutions. Hence, such developments are expected to drive the market growth during the forecast period.
The high cost of pelvic floor diagnostics products is one of the key challenges hindering market growth. Patients in need of pelvic floor diagnostics face challenges due to the high cost and limited accessibility of diagnostic procedures. Urodynamic equipment, including video urodynamics, uroflowmeters, electromyograph systems, and ultrasound, are classified as capital items and are expensive. This hinders early diagnoses, particularly in developing economies, where the aging population and demographic shift towards geriatric and male populations with prolapse and prostate disorders necessitate increased diagnostic services.
However, lifestyle changes and the rising prevalence of pelvic floor disorders further exacerbate the demand for diagnostics. Advancements in technology, such as MRI technology, telemedicine, and remote consultations, offer potential solutions to reduce costs and increase accessibility. Continuous patient monitoring and conservative treatments, including physical therapy, can also alleviate the financial burden of costly diagnostic procedures. Despite these advancements, the high cost of urodynamic equipment and procedures remains a significant barrier to widespread adoption and equitable access to pelvic floor diagnostics. Therefore, such factors are hindering the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market is a significant sector in healthcare, focusing on the assessment and treatment of pelvic floor disorders. This market encompasses various diagnostic tools and techniques used to evaluate the function and integrity of the pelvic floor muscles and organs, including veterinary scales. Key components of pelvic floor diagnostics include ultrasound, manometry, electromyography, and veterinary scales. These techniques help healthcare professionals diagnose conditions such as urinary incontinence, fecal incontinence, and pelvic organ prolapse in both human and veterinary patients. Additionally, the market includes devices like pessaries and vaginal cones for the treatment of these disorders. The demand for pelvic floor diagnostics is driven by an aging population, increasing awareness, and advancements in technology. Healthcare providers and patients alike benefit from accurate and effective diagnostic tools to improve patient outcomes and quality of life across human and veterinary healthcare settings.
Market Scope |
|
Report Coverage |
Details |
Page number |
166 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.7% |
Market Growth 2024-2028 |
USD 161.81 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.36 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Alacer Biomedica, Cadwell Industries Inc., Caldera Medical Inc., Diversatek Inc., FEMSelect Ltd., GE Healthcare Technologies Inc., Halo Medical Technologies, HC Italia srl, KARL STORZ SE and Co. KG, LABORIE MEDICAL TECHNOLOGIES CORP., MEDKONSULT medical technology s. r. o, Medspira LLC, Medtronic Plc, Neurosoft, Noraxon USA Inc., Renovia Inc., SRS Medical, Stryker Corp., THD S.p.A, and The Cooper Companies Inc. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.